Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Arcellx Inc (ACLX)

Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Arcellx Inc 800 Bridge Parkway Redwood City CA 94065 USA

www.arcellx.com P: 240-327-0603

Description:

Arcellx Inc. is a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc. is based in GAITHERSBURG, Md.

Key Statistics

Overview:

Market Capitalization, $K 2,814,778
Enterprise Value, $K 2,418,288
Shares Outstanding, K 53,290
Annual Sales, $ 110,320 K
Annual Net Income, $ -70,690 K
Last Quarter Sales, $ 63,150 K
Last Quarter Net Income, $ 19,840 K
EBIT, $ -89,880 K
EBITDA, $ -98,890 K
60-Month Beta 0.02
% of Insider Shareholders 6.24%
% of Institutional Shareholders 96.03%
Float, K 49,965
% Float 93.76%
Short Volume Ratio 0.65

Growth:

1-Year Return 25.82%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.42 on 02/28/24
Latest Earnings Date 05/13/24
Earnings Per Share ttm -1.47
EPS Growth vs. Prev Qtr 151.85%
EPS Growth vs. Prev Year 155.26%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ACLX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -20.96%
Return-on-Assets % -10.53%
Profit Margin % -64.08%
Debt/Equity 0.00
Price/Sales 26.30
Price/Cash Flow N/A
Price/Book 5.22
Book Value/Share 9.97
Interest Coverage -17.24
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar